Examples of how Warwick research supports businesses to deliver social, environmental and economic impact, and create new ventures.
Interview with CryoLogyx CEO Tom Congdon
University of Warwick spinout company CytoSwim is developing innovative single-use chips for sperm conditioning and separation, an integral part of IVF procedures used in both animal breeding and human assisted reproduction treatments.
Professor Helen Spencer-Oatey and Dr Daniel Dauber’s benchmarking tool allows universities to measure the effectiveness of the global education they offer.
Medherant has completed two Phase I clinical studies with its novel transdermal drug delivery technology, the TEPI Patch®. There is considerable interest in the transdermal delivery of drugs to overcome some of the disadvantages of oral administration, such as spikes in drug levels that can lead to side effects, and poor compliance.
A partnership between Coventry University, Coventry Cyrenians and University of Warwick, has developed the creative toolkit, Understanding Homelessness for a variety of users including teachers, youth groups, voluntary organisations and service providers.